Neutrophil-to-lymphocyte ratio evolution is an independent predictor of early progression of second-line nivolumab-treated patients with advanced non-small-cell lung cancers

Por Dusselier, Matthieu, Deluche, Elise, Delacourt, Nellie, Ballouhey, Julia, Egenod, Thomas, Melloni, Boris, Vergnenègre, Charlotte, Veillon, Rémi, Vergnenègre, Alain
Publicado no PLoS One (2019)

Staging of nutrition disorders in non‐small‐cell lung cancer patients: utility of skeletal muscle mass assessment

Por Antoun, Sami, Morel, Hugues, Souquet, Pierre‐Jean, Surmont, Veerle, Planchard, David, Bonnetain, Franck, Foucher, Pascal, Egenod, Thomas, Krakowski, Ivan, Gaudin, Hélène, Debieuvre, Didier
Publicado no J Cachexia Sarcopenia Muscle (2019)